Meralgia paresthetica is a nerve entrapment that may cause pain, numbness, hypersensivity, and paresthesias within the anterolateral region of the thigh, which is the area of distribution of the lateral femoral cutaneous...
Cockayne syndrome is a rare genetic disease that presents with growth retardation, premature aging, retinal and generalized neurologic abnormalities. The presented case is a 29-year-old male patient, who was previously d...
Objective: The clinical features of cervicogenic headache (CH) are characterized by unilateral, dull headache; precipitated by neck movements or external pressure over the great occipital nerve (GON). No conservative the...
With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks....
Blind Versus Ultrasound Guidance Injections: Lateral Femoral Cutaneous Nerve Blockage Revisited
Meralgia paresthetica is a nerve entrapment that may cause pain, numbness, hypersensivity, and paresthesias within the anterolateral region of the thigh, which is the area of distribution of the lateral femoral cutaneous...
Anti-N-methyl-D-aspartate receptor encephalitis in children: a case report
.
Cockayne Syndrome as a Rare Cause of Hemiplegia: Review of the Literature Accompanied by a Case Report
Cockayne syndrome is a rare genetic disease that presents with growth retardation, premature aging, retinal and generalized neurologic abnormalities. The presented case is a 29-year-old male patient, who was previously d...
The Effects of Repetitive Greater Occipital Nerve Blocks on Cervicogenic Headache
Objective: The clinical features of cervicogenic headache (CH) are characterized by unilateral, dull headache; precipitated by neck movements or external pressure over the great occipital nerve (GON). No conservative the...
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks....